Search Results

Enrollment Completed in Early Feasibility Study of Gore's Excluder Thoracoabdominal Branch Endoprosthesis

June 7, 2016—Gore & Associates announced completion of enrollment in an early feasibility study evaluating its Excluder thoracoabdominal branch endoprosthesis (TAMBE) for the treatment of aortic aneurysms involving the visceral branch vessels.

FDA Approves New Sizes for Gore Excluder AAA Endoprosthesis Contralateral Leg Component

November 29, 2011—Gore & Associates (Flagstaff, AZ) announced that it has received US Food and Drug Administration approval for the 23- and 27-mm-diameter sizes of the contralateral leg component of the Gore Excluder AAA endoprosthesis for treatment of abdominal aortic aneurysm (AAA) by endovascular aneurysm repair (EVAR).

FDA Approves Cordis' InCraft AAA Stent Graft System

November 28, 2018—Cordis, a Cardinal Health company, announced FDA approval for the low-profile InCraft abdominal aortic aneurysm (AAA) stent graft system for endovascular aneurysm repair (EVAR) of infrarenal AAAs in complex access anatomies.

Early Feasibility Study Begins for Gore TAG Thoracic Branch Endoprosthesis to Treat Aortic Arch Aneurysms

April 28, 2015—Gore & Associates announced that the first brachiocephalic-treated patient was enrolled in the Gore TAG thoracic branch endoprosthesis early feasibility study.

New Sizing Options for Gore's Excluder AAA Stent Graft Approved in Europe

July 3, 2012—Gore & Associates (Flagstaff, AZ) announced CE Mark approval for the 23- and 27-mm-diameter sizes of the contralateral leg component of the Gore Excluder AAA endoprosthesis for the treatment of abdominal aortic aneurysm (AAA) by endovascular aneurysm repair (EVAR).

Medtronic Gains FDA Approval for Endurant II Aorto-Uni-Iliac Device, 510(k) Clearance for Sentrant Introducer Sheath

May 30, 2013—With the 2013 Vascular Annual Meeting underway in San Francisco, Medtronic Inc. (Minneapolis, MN) has announced the US Food and Drug Administration approval of its Endurant II Aorto-Uni-Iliac (AUI) Stent Graft System and 510(k) clearance for its Sentrant Introducer Sheath.

FDA Approves Medtronic's Endurant Stent Graft for EVAR

December 21, 2010—Medtronic, Inc. (Minneapolis, MN) announced that the US Food and Drug Administration approved the company's Endurant stent graft system for the endovascular repair of abdominal aortic aneurysms.

FDA Approves 45-mm Gore TAG

June 7, 2010—W.

FDA Approves 45-mm Gore TAG Device

June 7, 2010—W.

Two-Year Data Presented for Medtronic's Endurant AAA Stent Graft

April 16, 2012—Medtronic, Inc. (Minneapolis, MN) announced that the 2-year results from its United States clinical study of the Endurant abdominal aortic aneurysm (AAA) stent graft system were presented at the Charing Cross International Symposium in London.

One-Year Data Presented for Medtronic's Endurant AAA Stent Graft

November 10, 2010—Medtronic, Inc. (Minneapolis, MN) announced results for its Endurant stent graft system for the treatment of abdominal aortic aneurysms.

First Implant Completed in Thoracoabdominal Aortic Aneurysm Clinical Study of Gore Excluder Device

January 12, 2016—Gore & Associates announced the first implant in the United States of the Gore Excluder thoracoabdominal branch endoprosthesis in a clinical study for the treatment of aortic aneurysms involving the visceral branch vessels.

SVS Elects 2018–2019 Leadership

July 12, 2018—The Society for Vascular Surgery (SVS) announced that the society's leaders for 2018–2019 were elected at the SVS Vascular Annual Meeting held June 20–23 in Boston, Massachusetts.